← Back
$XERS All transactions

Xeris Biopharma Holdings, Inc.

F

$ Value

$815K

Shares

110,750

Price

$7

Filed

Feb 2

Insider

Name

Shannon John Patrick Jr

Title

See Remarks

CIK

0001553595

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-31

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,935,578

Footnotes

These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the "Plan"). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued employment through such vesting date. | Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026. | These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in equal annual installments over three years, subject to continued service through such vesting date.

Filing Info

Accession No.

0001553595-26-000004

Form Type

4

Issuer CIK

0001867096

Shannon John Patrick Jr's History

Date Ticker Type Value
2026-01-31 XERS F $869K
2026-01-31 XERS F $822K
2026-01-31 XERS F $815K
2026-01-30 XERS A $0
2026-01-30 XERS A $0
2026-01-05 XERS $176K
2026-01-05 XERS M $100K
2026-01-05 XERS M $39K
2026-01-05 XERS M $11K
2026-01-05 XERS M $0

Other Insiders at XERS (90d)

Insider Bought Sold Last
Shannon John Patrick Jr
See Remarks
2026-01-31
Hecht Beth
See Remarks
$224K 2026-04-01
Pieper Steven
See Remarks
2026-01-31
Brady James Aloysius $60K 2026-03-30
McCulloch Kevin
See Remarks
2026-01-31
Nguyen Anh Tu
See Remarks
2026-01-30